Table 2.
Clinical details of human frontal cortex tissue used for biochemical analysis (from QSBB)
| Subject | Gender | Age (years) | PMD (h) | Pathology |
|---|---|---|---|---|
| Control 1 | F | 85 | 37 | N/A |
| Control 2 | M | 93 | 112 | N/A |
| Control 3 | F | 91 | 98.5 | N/A |
| Control 4 | M | 87 | 36 | N/A |
| iPD 1 | F | 69 | 52.5 | Limbic |
| iPD 2 | M | 70 | 61.2 | Limbic |
| iPD 3 | F | 87 | 47.45 | Limbic |
| iPD 4 | M | 75 | 48 | Limbic |
| G2019S 1 | F | 80 | 44.4 | Limbic |
| G2019S 2 | F | 81 | 15 | Limbic |
| G2019S 3 | F | 84 | 32.2 | Limbic |
| G2019S 4 | F | 72 | 24.55 | Limbic |
iPD, idiopathic Parkinson's disease; Limbic, limbic subtype of Lewy body pathology according to McKeith consensus criteria for the classification of DLB; N/A, non-applicable; PMD, postmortem delay.